投稿咨詢
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.
More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.
《Current Drug Metabolism》是一本由BENTHAM SCIENCE PUBL LTD出版商出版的專業醫學期刊，該刊創刊于2000年，刊期Quarterly，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 4區，小類學科：生化與分子生物學 4區；藥學 4區；在JCR（Journal Citation Reports）分區等級為Q3。該刊發文范圍涵蓋生化與分子生物學等領域，旨在及時、準確、全面地報道國內外生化與分子生物學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為3.408，平均審稿速度偏慢,4-8周。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 4區 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 PHARMACOLOGY & PHARMACY 藥學 | 4區 4區 | 否 | 是 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q3 | PHARMACOLOGY & PHARMACY | Q3 | 3.408 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | Q3 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 3.408 | 97 | 0.00% | 55.79% | 未開放 | 偏慢,4-8周 |
課題、SCI/EI/SSCI怎么寫？